Product logo
  • Home
  • Sign Up
Product logo

Ajanta Pharma Ltd

News

Switch to
Share
    Home
    Sign Up

    Ajanta Pharma Ltd

    AJANTPHARM
    1,691.009.40 (-0.55%)
    Investment Checklist
    BasicPro

    Intrinsic Value
    Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

    Current price is less than the intrinsic value

    ROE vs FD rates
    Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

    Stock has been generating better return on equity than bank FD

    Dividend Returns
    A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

    Stock doesn't offer attractive dividend returns

    Entry Point
    High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

    Good time to consider, as stock is not in overbought zone

    No Red Flags
    ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks

    Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

    Loading...
    Go pro! Unlock deeper insights
    Get your Zerodha accountOpen Now
    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    993

    News & Opinions

    993
    Articles & Videos
    News Thumbnail

    Buy Ajanta Pharma; target of Rs 2350: YES Securities

    1 week ago•Moneycontrol

    News Thumbnail

    Broker’s call: Ajanta Pharma (Buy)

    1 week ago•The Hindu Businessline

    News Thumbnail

    Buy Ajanta Pharma; target of Rs 2080: Motilal Oswal

    1 week ago•Moneycontrol

    News Thumbnail

    Yes Securities sees 42% upside in pharma stock that just announced bonus shares

    1 week ago•Livemint

    News Thumbnail

    Ajanta Pharma Q4 Review - Focus On Outperformance In Branded Generics Segment: Motilal Oswal

    1 week ago•Bloomberg Quint

    News Thumbnail

    Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4

    1 week ago•Business Standard

    News Thumbnail

    Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore

    2 weeks ago•Moneycontrol

    © Powered byTickertape.ViewAJANTPHARMon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019